Origen de la red de primer grado William P. Whitaker.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Extinct | Biotechnology | 13 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a William P. Whitaker a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| REPLIGEN CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
Diacrin, Inc. (Delaware)
 Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Diacrin, Inc. develops human cell transplant therapeutic products. The company is headquartered in Wilmington, DE. | Medical Specialties | Director of Finance/CFO | |
| PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Corporate Officer/Principal | |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DYAX CORP. | Pharmaceuticals: Major | Director/Board Member | |
| Aai International, Inc. | Corporate Officer/Principal | ||
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Director of Finance/CFO | |
| CHIASMA, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
TVM Capital GmbH
 TVM Capital GmbH Investment ManagersFinance TVM Capital GmbH (TVMC) is an international venture capital firm headquartered in Munich, Germany. Founded in 1983, the firm was formerly known as Techno Venture Management. | Investment Managers | Chairman | |
| EVOTEC SE | Pharmaceuticals: Major | Director/Board Member | |
WorldStreet Corp.
 WorldStreet Corp. Packaged SoftwareTechnology Services WorldStreet Corp. develops enterprise software applications. The American company was founded by Paul I. Walborsky. | Packaged Software | Director of Finance/CFO | |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| PROTARA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Kansas | College/University | Undergraduate Degree Undergraduate Degree | |
TVM Life Science Management GmbH
 TVM Life Science Management GmbH Miscellaneous Commercial ServicesCommercial Services Part of TVM Capital GmbH, TVM Life Science Management GmbH provides management services. The company is based in Munich, Germany. The CEO of the German company is Stefan Fischer. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Chairman | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
SpePharm AG
 SpePharm AG Pharmaceuticals: MajorHealth Technology SpePharm AG acquires, registers, and markets medical value medicines for the hospital sector. Its brands include Dantrium IV, Dantrium, Dantamacrin, Lymphoseek and Mugard. The company was founded in 2012 and is headquartered in Luzern, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Versantis AG
 Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Biotechnology | Chief Executive Officer | |
| ALLENA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Boston College | College/University | Undergraduate Degree | |
| TME PHARMA N.V. | Biotechnology | Chairman | |
leon-nanodrugs GmbH
 leon-nanodrugs GmbH Pharmaceuticals: MajorHealth Technology leon-nanodrugs GmbH develops oral and parenteral drugs. The firm's services include nanotechnology in medicine, MJR technology, pipeline, partnering with leon and leon network. The company was founded by Wolfgang Beier and Cornelia Beier in 2011 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Chairman | |
| Glaxo, Inc. | Corporate Officer/Principal | ||
| Wheaton College (Illinois) | College/University | Undergraduate Degree | |
| The Wayne State University School of Medicine | College/University | Doctorate Degree | |
Stowers Institute for Medical Research
 Stowers Institute for Medical Research Miscellaneous Commercial ServicesCommercial Services Stowers Institute for Medical Research is a non-profit organization that conducts foundational research to uncover the secrets underlying fundamental biological processes. The institute is based in Kansas City, MO, and has subsidiaries in the United States. The institute has a unique funding model that provides ongoing support for research through the annual dividends from American Century Investments. The institute is dedicated to encouraging motivated individuals to pursue science or science-related professions, from their accredited graduate school to their training programs for post-docs, post-bacs, and undergrads. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The California State University | College/University | Undergraduate Degree | |
AbFero Pharmaceuticals, Inc.
 AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Abfero Pharmaceuticals, Inc. engages in the development of pharmaceutical products. It develops oral iron chelators for the treatment of diseases of iron-overload. The company was founded by Steven K. Burke, Raymond J. Bergeron, and Thomas X. Neenan and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Weill Cornell Medical College | College/University | Doctorate Degree | |
Vitra Bioscience, Inc.
 Vitra Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Vitra Bioscience, Inc. develops technologies for biological research and drug discovery. Its technology includes cellcard system and cellplex assays which facilitate multiple cell-types and parameters to be evaluated. The cellcard imaging system collects images and then analyzed with proprietary software. The company was founded by Simon Goldbard and is headquartered in Mountain View, CA. | Pharmaceuticals: Other | Corporate Officer/Principal | |
AL-S Pharma AG
 AL-S Pharma AG Pharmaceuticals: MajorHealth Technology AL-S Pharma AG engages in the development and marketing of pharmaceutical products. The company was founded by Michael Salzmann on September 19, 2016 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Chairman |
Estadísticas
Internacional
| Estados Unidos | 32 |
| Alemania | 11 |
| Suiza | 5 |
| Italia | 2 |
| Países Bajos | 2 |
Sectorial
| Health Technology | 30 |
| Consumer Services | 10 |
| Commercial Services | 6 |
| Health Services | 2 |
| Finance | 2 |
Operativa
| Director/Board Member | 51 |
| Corporate Officer/Principal | 32 |
| Undergraduate Degree | 13 |
| Chairman | 12 |
| Chief Executive Officer | 11 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Hubert Birner | 27 |
| Gregory D. Phelps | 17 |
| Brendan M. O'Leary | 15 |
| Joseph E. Tyler | 13 |
| Timothy Noyes | 12 |
| Mark J. Fitzpatrick | 12 |
| Muffy Carter | 11 |
| Steven Burke | 10 |
| Daniel Gottlieb | 8 |
| F. Nicholas Franano | 7 |
| Pamela Gustafson | 7 |
| Kimberly S. Bland | 4 |
| Marco D. Wong | 4 |
- Bolsa de valores
- Insiders
- William P. Whitaker
- Conexiones Empresas
